MBOT
Microbot Medical Inc
1.30$
-5.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Microbot Medical Inc (MBOT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 | -14 | -9.2 | -12 | -6.3 | -11 | -10 | -8.5 | -11 | -12 | -16 | -21 | -23 | -25 | -25 | -22 | -20 | -23 | -27 | -0.8 | -0.8 | -4.9 | -5.3 | -6.5 | -7.3 | -9.4 | -12 | -8.5 | -8.8 | -13 | |
| 1.8 | 2.1 | 2.8 | 2.0 | 2.8 | 1.9 | 0.4 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.2 | 1.7 | 1.5 | 1.2 | 1.0 | 1.1 | 1.3 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| – | – | – | – | – | 1,242 | -469 | 251 | 830 | 355 | – | – | 3.9 | 4.2 | 3.9 | 3.3 | 2.9 | 2.6 | 2.0 | 4.2 | 0.7 | 0.5 | 1.4 | 1.1 | 1.9 | 1.4 | 1.8 | 1.4 | 1.3 | 1.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9 | 2.9 | -0.7 | 2.2 | 3.4 | 0.4 | 2.6 | 1.4 | 1.0 | 1.9 | 1.4 | – | – | – | – | |
| 1.5 | -3.1 | 0.1 | -0.1 | 3.5 | -1.5 | 0.1 | 1.9 | 1.9 | 1.8 | -0.6 | 1.1 | -1.8 | -1.2 | -1.6 | 0.8 | -1.2 | 2.5 | 1.7 | 0.1 | 0.9 | -0.1 | 0.4 | -0.3 | 0.0 | 0.2 | -0.2 | 0.0 | 0.9 | -1.5 | |
| 4.4 | 10 | 2.6 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.7 | 0.8 | 1.3 | 1.3 | 0.3 | 0.7 | 0.9 | 0.3 | 0.1 | 4.7 | 0.9 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | |
| – | 10 | 1.0 | 10.0 | 0.4 | 7.7 | -0.2 | -0.2 | -0.7 | -0.8 | -1.3 | -27 | 24 | 3.7 | -0.9 | -3.4 | -11 | 9.0 | -0.4 | 0.0 | 0.0 | -0.1 | -0.2 | -2.5 | -2.8 | 3.2 | -3.8 | 2.0 | 1.5 | -72 | |
| – | – | – | – | – | – | 10,365 | 12,291 | 15,330 | 11,738 | – | – | – | – | – | 0.0 | 0.0 | 14 | 8.2 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -0.4 | -0.5 | -0.4 | -0.1 | -0.3 | -0.5 | -0.4 | 0.4 | 13 | – | 37 | 0.0 | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2 | -0.2 | 14 | 5.8 | -2.4 | 0.8 | – | 0.0 | – | – | – | – | – | – | – | |
| 14 | -0.3 | 0.1 | -1.2 | 7.2 | 10 | 0.8 | 18 | 40 | 6.2 | 35 | 6.0 | 19 | 30 | 6.6 | 19 | 26 | 36 | 22 | 0.4 | 3.1 | 13 | 0.0 | 37 | -3.4 | 4.3 | 4.3 | 6.6 | 7.9 | 86 | |
| 10 | -4.0 | -8.1 | -3.1 | 1.3 | 7.6 | -9.5 | 8.8 | 28 | -6.5 | 17 | -42 | 20 | 8.6 | -19 | -6.4 | -4.8 | 22 | -5.6 | -0.4 | 2.3 | 8.1 | -5.6 | 28 | -13 | -6.2 | -11 | 0.0 | 0.6 | 0.8 | |
| -14 | -24 | -12 | -13 | -6.5 | -11 | -10 | -8.7 | -12 | -13 | -17 | -22 | -23 | -25 | -25 | -22 | -20 | -28 | -28 | -0.8 | -0.8 | -4.9 | -5.5 | -6.7 | -7.3 | -9.4 | -12 | -8.6 | -8.9 | -13 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.